Bottom line
GSKH vs FSPSX: the short answer
GSKH (GSK plc ADRhedged) and FSPSX (Fidelity International Index Fund) are both etfs.
But FSPSX is far broader, holding 705 positions to 3 for GSKH, so beyond the top names it adds exposure GSKH doesn't have.
FSPSX is cheaper at 0.035% vs 0.19% — a difference of $16 a year per $10,000 invested.
Updated Nov 19, 2026
GSKH vs FSPSX side by side
| GSKH | FSPSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | DWS (Xtrackers) | Fidelity |
| Category | International Stock | International Stock |
| Expense ratio | 0.19% | 0.035% |
| Annual cost per $10k | $19 | $3.5 |
| 10-yr cost on $10k (prospectus) | $243 | $45 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +32.0% |
| 5-yr return (annualized) | — | +9.1% |
| 10-yr return (annualized) | — | +8.4% |
| Best quarter | — | +18.3% |
| Worst quarter | — | −23.0% |
| Net assets (fund) | $737.4K | $83.7B |
| Number of holdings | 3 | 705 |
| Portfolio turnover | % | 4% |
| Returns as of | — | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
GSKH and FSPSX share none of their top holdings.
GSKH top 10
- Gsk Plc — 96.79%
- Dreyfus Trsry Securities — 2.57%
- Canadian Imperial Bank Of Commerce — -0.19%
FSPSX top 10
- Asml Holding Nv — 2.82%
- Hsbc Holdings Plc — 1.45%
- Roche Holding Ag — 1.33%
- Astrazeneca Plc — 1.30%
- Novartis Ag — 1.29%
- Nestle Sa — 1.18%
- Shell Plc — 1.08%
- Siemens Ag — 1.07%
- Bhp Group Ltd — 1.02%
- Mitsubishi Ufj Financial Group Inc — 0.95%
FAQ
What is the difference between GSKH and FSPSX?
GSKH (GSK plc ADRhedged) and FSPSX (Fidelity International Index Fund) are both etfs. But FSPSX is far broader, holding 705 positions to 3 for GSKH, so beyond the top names it adds exposure GSKH doesn't have.
Which is cheaper, GSKH or FSPSX?
FSPSX has the lower expense ratio (0.035%).
Should I own both GSKH and FSPSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.